Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, presenting promising enhancements across several medical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA delivers a safer, additional reputable substitute for therapeutic use, signifi